Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Boon

Showing results (201-210 of 293) with videos related to

Pageof 30
Sort By:
The British Journal of Ophthalmology|July 14, 2018
Discrepancy in current central serous chorioretinopathy classificationSumit Randhir Singh, Alexandre Matet, Elon H C van Dijk, et al.
Medicine|May 6, 2016
Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer PatientsElon H C van Dijk, Danique E M Duits, Mieke Versluis, et al.
Acta Ophthalmologica|December 5, 2025
Seasonal variation in the incidence of central serous chorioretinopathy: A systematic review and meta-analysisI Made Ferdiko Hutamadella, Emil Ørnberg, Mark P Breazzano, et al.
Investigative Ophthalmology & Visual Science|October 18, 2014
Foveal sparing in Stargardt diseaseRamon A C van Huet, Nathalie M Bax, Sarah C Westeneng-Van Haaften, et al.
Retina (Philadelphia, Pa.)|December 1, 2017
FAMILIAL CENTRAL SEROUS CHORIORETINOPATHYElon H C van Dijk, Rosa L Schellevis, Myrte B Breukink, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 25, 2019
Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakageThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|April 15, 2020
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE TrialThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|November 14, 2020
Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous ChorioretinopathyThomas J van Rijssen, Elon H C van Dijk, Greet Dijkman, et al.
Investigative Ophthalmology & Visual Science|July 21, 2012
Genetic, behavioral, and sociodemographic risk factors for second eye progression in age-related macular degenerationYara T E Lechanteur, Johannes P H van de Ven, Dzenita Smailhodzic, et al.
American Journal of Ophthalmology|March 18, 2026
Long-term follow-up of PLACE and SPECTRA trials: outcomes after successful and unsuccessful half-dose photodynamic therapy for chronic central serous chorioretinopathyFemke M van den Tillaart, Jennifer M Chang-Wolf, Helena M A Feenstra, et al.
Pageof 30

Showing results (201-210 of 293) with videos related to

Sort By:
Pageof 30
The British Journal of Ophthalmology|July 14, 2018
Discrepancy in current central serous chorioretinopathy classificationSumit Randhir Singh, Alexandre Matet, Elon H C van Dijk, et al.
Medicine|May 6, 2016
Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer PatientsElon H C van Dijk, Danique E M Duits, Mieke Versluis, et al.
Acta Ophthalmologica|December 5, 2025
Seasonal variation in the incidence of central serous chorioretinopathy: A systematic review and meta-analysisI Made Ferdiko Hutamadella, Emil Ørnberg, Mark P Breazzano, et al.
Investigative Ophthalmology & Visual Science|October 18, 2014
Foveal sparing in Stargardt diseaseRamon A C van Huet, Nathalie M Bax, Sarah C Westeneng-Van Haaften, et al.
Retina (Philadelphia, Pa.)|December 1, 2017
FAMILIAL CENTRAL SEROUS CHORIORETINOPATHYElon H C van Dijk, Rosa L Schellevis, Myrte B Breukink, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 25, 2019
Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakageThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|April 15, 2020
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE TrialThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|November 14, 2020
Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous ChorioretinopathyThomas J van Rijssen, Elon H C van Dijk, Greet Dijkman, et al.
Investigative Ophthalmology & Visual Science|July 21, 2012
Genetic, behavioral, and sociodemographic risk factors for second eye progression in age-related macular degenerationYara T E Lechanteur, Johannes P H van de Ven, Dzenita Smailhodzic, et al.
American Journal of Ophthalmology|March 18, 2026
Long-term follow-up of PLACE and SPECTRA trials: outcomes after successful and unsuccessful half-dose photodynamic therapy for chronic central serous chorioretinopathyFemke M van den Tillaart, Jennifer M Chang-Wolf, Helena M A Feenstra, et al.
Pageof 30